Themes
Mirum expands rare disease portfolio with digestive disorder drugs
Mirum Therapeutics acquired Travere’s Cholbam and Chenodal drugs that are approved to treat rare disorders.
Mirum Therapeutics acquired Travere’s Cholbam and Chenodal drugs that are approved to treat rare disorders.